Emergent BioSolutions (EBS) Asset Utilization Ratio (2011 - 2026)

Emergent BioSolutions' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.51 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 5.07% year-over-year to 0.51; the TTM figure through Mar 2026 stood at 0.51 (down 5.07% YoY), while the FY2025 annual figure was 0.55, down 15.55% from the prior year.
• Asset Utilization Ratio was 0.51 for Q1 2026 at Emergent BioSolutions, down from 0.53 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.65 in Q1 2024 to a low of 0.32 in Q1 2023.
• Historically, Asset Utilization Ratio has averaged 0.53 across 5 years, with a median of 0.54 in 2023.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio sank 46.13% in 2023, then jumped 104.61% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.37 in 2022, then soared by 53.16% to 0.56 in 2023, then grew by 3.61% to 0.59 in 2024, then slipped by 8.64% to 0.53 in 2025, then fell by 4.04% to 0.51 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.51 (Q1 2026), 0.53 (Q4 2025), and 0.55 (Q3 2025), per Business Quant data.